4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-039938
SVP, Chief Accounting Officer sold 379 shares at $9.45 ($3,582)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2026-06-01 | Sale 10b5-1 | −379 | $9.45 | $3,582 | 61,902 | D |
| Open-market sales · 379 sh · avg $9.45 · $3,582 | |||||||
Loading xslF345X06/wk-form4_1780435911.xml…